Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).
about
Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.Lac operator analogues: bromodeoxyuridine substitution in the lac operator affects the rate of dissociation of the lac repressor.Sequence of spontaneous Epstein-Barr virus activation and selective DNA synthesis in activated cells in the presence of hydroxyureaSynthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints)Effects of 5-bromodeoxyuridine and 5-iododeoxyuridine on a latent herpes simplex virus infection.Identification of an intracellular precursor to DNA excreted by human lymphocytes.Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus.Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.Neoplasms, differentiations and mutations.Are viruses important in carcinogenesis?Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines.Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.Tubuloreticular structures in human lymphoid cell lines. A cell biological study.Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell linesPersistence of the cytomegalovirus genome in human cells.Cycloheximide induction of xenotropic type C virus from synchronized mouse cells: metabolic requirements for virus activation.Stimulation of adenovirus replication in simian cells in the absence of a helper virus by pretreatment of the cells with iododeoxyuridine.Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin.Cytomegalovirus replication in cells pretreated with 5-iodo-2'-deoxyuridineEffect of dibutyryl cyclic AMP on the induction of Epstein-Barr virus in hybrid cells.Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions.Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.Isolation of Chlamydia trachomatis by use of 5-iodo-2-deoxyuridine-treated cellsTumor initiators and promoters in the induction of Epstein-Barr virusReplication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cellsExpression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines.Epstein-Barr virus-specific RNA. I. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid cell lines.Epstein-barr virus-specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive, and prooductive infections.Prolongation of herpes simplex virus latency in cultured human cells by temperature elevation.Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells.Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation.Studies on Epstein-Barr virus-associated antigens.Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C.trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans.Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells.Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression.Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium.
P2860
Q33993543-C3294B00-AC2B-488B-BE0E-699F261B14CAQ34728297-42C50D9D-46D8-4F3E-B3A2-D73D92B6121CQ34728686-2FC35F84-3EDA-419D-A40F-0171C974BA54Q34766432-7163861C-53E7-4EF5-9F98-0C9D2E861DD6Q34934069-FADDBFDA-B395-4ECC-BA29-356616721523Q35024389-C2A970A7-E837-4D97-8D4D-27A16D7F850EQ35082213-541D1B7D-7EBA-49AA-9F7A-F76FB6948888Q35237835-913EFEDA-AE28-4CD3-A615-9BCCB7DD6A63Q35875063-5EB86A0F-C486-4155-9DBB-39C4EC6F21A4Q35875067-9EED611D-23A1-43A3-B58F-DFE155C0E7A8Q35898605-93099539-1A2F-4791-9EA6-5AEBF335B660Q35982261-0F3A7F18-A826-46C2-9609-1F6A2AE80E6CQ36130526-3E97144C-DDF4-402A-B420-F158ACDB1C2DQ36430509-11341FA2-5D8B-4CF2-AA61-14F9C78D5F60Q36502186-1C150325-12E0-44C6-B806-E2637816547DQ36529722-C4A82C2A-2DC1-4A20-817E-D5BA7ABCE95BQ36530800-BE68C381-32D8-4666-8F42-8C28337BECCEQ36541283-398A504C-1EF5-413D-B457-C0835A90E237Q36553512-2EC1FC2F-A83E-40B6-87A4-454919EB005CQ36596832-78BCBD2D-F2CD-4688-B4C2-D2AC3C41793DQ36829336-2281DB43-34E3-4846-B6B9-3369C8246B5DQ36906960-F4026B35-26D3-4AC2-9EDE-9443D6DB52C7Q36922358-33EA9E3C-CD71-4F9F-9CB0-FA31277DDE54Q37241922-1CDE8176-502C-49A3-8A4C-A37D5890337DQ37315125-3F46A272-DAF7-4CD7-8985-BD7F56BF337AQ37432761-C2F16FED-4433-4B08-A208-0D29BD708D93Q37451541-D3A86A4C-FE22-4FDE-BDF4-929057D8D53AQ37502704-7A222372-BAEA-493B-9FBC-E10C3CA11304Q37505215-AB000A3B-13AA-410D-91BF-CF0B085767C9Q37506975-0EE5FA5F-AD24-4CDF-80D8-BE315419F6DEQ37601607-7BA31483-74F1-4A63-9E75-224DAB511BA9Q39826959-7905D7EC-3DFC-4ED8-A95D-D0485330C1FAQ39955396-0FA112DF-5CB3-4CB8-B668-5829034EB9E4Q40045269-66DF9154-CE34-42E1-BFA1-197CBA2CC7D2Q40115777-60B2AF6C-1877-450A-83A0-D57E4B54CF9FQ40125966-D0B72476-46C6-4183-9377-385111E43119Q40131194-4544A13A-B94F-46A7-9ABE-D82DBFBADC1EQ40139597-92386871-FA43-4857-8E79-DCBB20F3E00AQ40140963-3749B34C-4C06-41AE-BCF9-651155E53541Q40141491-8B27236C-8F65-42BE-99FF-BFE38C1EA4F0
P2860
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).
description
1972 nî lūn-bûn
@nan
1972 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Activation of Epstein-Barr vir ...... mmunofluorescence-leukocytes).
@ast
Activation of Epstein-Barr vir ...... mmunofluorescence-leukocytes).
@en
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells
@nl
type
label
Activation of Epstein-Barr vir ...... mmunofluorescence-leukocytes).
@ast
Activation of Epstein-Barr vir ...... mmunofluorescence-leukocytes).
@en
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells
@nl
prefLabel
Activation of Epstein-Barr vir ...... mmunofluorescence-leukocytes).
@ast
Activation of Epstein-Barr vir ...... mmunofluorescence-leukocytes).
@en
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells
@nl
P2860
P356
P1476
Activation of Epstein-Barr vir ...... mmunofluorescence-leukocytes).
@en
P2093
P2860
P356
10.1073/PNAS.69.1.83
P407
P577
1972-01-01T00:00:00Z